Patents Assigned to Sulfagenix Inc
Treatment of viral infections
​
Patent Application number: WO2021226037A1
Status: Application
Filed: May 04, 2020
Date of Patent: Pending
Assignee: Sulfagenix, Inc.
Inventors: Gabriel GOJON-ROMANILLOS, Gabriel GOJON-ZORRILLA
Preparation and compositions of zero-valent sulphur having high bioavailability, and uses thereof
​
Assignee: Sulfagenix, Inc.
Inventors: Gabriel GOJON-ROMANILLOS, Gabriel GOJON-ZORRILLA
Australia
Patent number: AU2012321444B2
Status: Granted
Date of patent: 08 Oct 2015
​
European Patent Office
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
Germany
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
United Kingdom
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
Sweden
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
Mexico
Patent number: MX360050B
Status: Granted
Date of patent: 14 Nov 2018
​
China
Patent number: CN104080339B
Status: Granted
Date of patent: 28 Sep 2016
​
​
Australia
Patent number: AU2015210403B2
Status: Granted
Date of patent: 23 Mar 2017
​
Belgium
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
Spain
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
Italy
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
Hong Kong
Patent number: HK1200277A
Status: Pending
Date of patent: 24 Apr 2019
​
Japan
Patent number: JP5992525B2
Status: Granted
Date of patent: 14 Sep 2016
Canada
Patent number: CA2847589A1
Status: Granted
Date of patent: 18 Apr 2013
​
Switzerland
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
France
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
Netherlands
Patent number: EP2756757B1
Status: Granted
Date of patent: 24 Apr 2019
​
United States
Patent number: US8771755
Status: Granted
Date of patent: 08 Jul 2014
​
Brazil
Patent number: BR112014005144A2
Status: Granted
Date of patent: 18 Apr 2017
Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
​
Assignee: Sulfagenix, Inc
Inventors: Gabriel GOJON-ROMANILLOS